Stephanie Ware

Dr. Stephanie Ware

Departments of Pediatrics and Medical and Molecular Genetics, Indiana University School of Medicine, Herman B Wells Center for Pediatric Research,1044 West Walnut Street | R4-W227, Indianapolis, IN 46202, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
RHRobert B. Hinton
Robert B. Hinton
Stephanie WareStephanie Ware
Stephanie Ware
Heart failure (HF) is a complex clinical syndrome resulting from diverse primary and secondary causes and shared pathways of disease progression, correlating with substantial mortality, morbidity, and cost. HF in children is most commonly attributable to coexistent congenital heart disease, with different risks depending on the specific type of malformation. Current management and therapy for HF in children are extrapolated from treatment approaches in adults. This review discusses the causes, epidemiology, and manifestations of HF in children with congenital heart disease and presents the clinical, genetic, and molecular characteristics that are similar or distinct from adult HF. The objective of this review is to provide a framework for understanding rapidly increasing genetic and molecular information in the challenging context of detailed phenotyping. We review clinical and translational research studies of HF in congenital heart disease including at the genome, transcriptome, and epigenetic levels. Unresolved issues and directions for future study are presented.

1 June 2015 in Clinics in Perinatology
Verified
Journal Article
Closed access
JCJason R. Cowan
Jason R. Cowan
Stephanie WareStephanie Ware
Stephanie Ware

1 January 2015 in Heart Rhythm
Verified
Journal Article
Closed access
NBNicole J. Boczek
Nicole J. Boczek
EMErin M. Miller
Erin M. Miller
DYDan Ye
Dan Ye
VNVladislav V. Nesterenko
Vladislav V. Nesterenko
DTDavid J. Tester
David J. Tester
Stephanie WareStephanie Ware
Stephanie Ware

4 May 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
Stephanie WareStephanie Ware
Stephanie Ware
JWJames D. Wilkinson
James D. Wilkinson
MTMuhammad Tariq
Muhammad Tariq
JSJeffrey A. Schubert
Jeffrey A. Schubert
ASArthi Sridhar
Arthi Sridhar
PGPediatric Cardiomyopathy Registry Study Group
Pediatric Cardiomyopathy Registry Study Group
Background: Pediatric cardiomyopathy is a genetically heterogeneous disease with substantial morbidity and mortality. Current guidelines recommend genetic testing in children with hypertrophic, dilated, or restrictive cardiomyopathy, but practice variations exist. Robust data on clinical testing practices and diagnostic yield in children are lacking. This study aimed to identify the genetic causes of cardiomyopathy in children and to investigate clinical genetic testing practices. Methods and Results: Children with familial or idiopathic cardiomyopathy were enrolled from 14 institutions in North America. Probands underwent exome sequencing. Rare sequence variants in 37 known cardiomyopathy genes were assessed for pathogenicity using consensus clinical interpretation guidelines. Of the 152 enrolled probands, 41% had a family history of cardiomyopathy. Of 81 (53%) who had undergone clinical genetic testing for cardiomyopathy before enrollment, 39 (48%) had a positive result. Genetic testing rates varied from 0% to 97% between sites. A positive family history and hypertrophic cardiomyopathy subtype were associated with increased likelihood of genetic testing ( P =0.005 and P =0.03, respectively). A molecular cause was identified in an additional 21% of the 63 children who did not undergo clinical testing, with positive results identified in both familial and idiopathic cases and across all phenotypic subtypes. Conclusions: A definitive molecular genetic diagnosis can be made in a substantial proportion of children for whom the cause and heritable nature of their cardiomyopathy was previously unknown. Practice variations in genetic testing are great and should be reduced. Improvements can be made in comprehensive cardiac screening and predictive genetic testing in first‐degree relatives. Overall, our results support use of routine genetic testing in cases of both familial and idiopathic cardiomyopathy. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01873963.

17 June 2019 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
MBMartin D. Burkhalter
Martin D. Burkhalter
ASArthi Sridhar
Arthi Sridhar
PSPedro Sampaio
Pedro Sampaio
AJAna Raquel Marques Jacinto
Ana Raquel Marques Jacinto
MBMartina S. Burczyk
Martina S. Burczyk
MPMelanie Philipp
Melanie Philipp
About 1% of all newborns are affected by congenital heart disease (CHD). Recent findings identify aberrantly functioning cilia as a possible source for CHD. Faulty cilia also prevent the development of proper left-right asymmetry and cause heterotaxy, the incorrect placement of visceral organs. Intriguingly, signaling cascades such as mTOR that influence mitochondrial biogenesis also affect ciliogenesis, and can cause heterotaxy-like phenotypes in zebrafish. Here, we identify levels of mitochondrial function as a determinant for ciliogenesis and a cause for heterotaxy. We detected reduced mitochondrial DNA content in biopsies of heterotaxy patients. Manipulation of mitochondrial function revealed a reciprocal influence on ciliogenesis and affected cilia-dependent processes in zebrafish, human fibroblasts and Tetrahymena thermophila. Exome analysis of heterotaxy patients revealed an increased burden of rare damaging variants in mitochondria-associated genes as compared with 1000 Genome controls. Knock down of such candidate genes caused cilia elongation and ciliopathy-like phenotypes in zebrafish, which could not be rescued by RNA encoding damaging rare variants identified in heterotaxy patients. Our findings suggest that ciliogenesis is coupled to the abundance and function of mitochondria. Our data further reveal disturbed mitochondrial function as an underlying cause for heterotaxy-linked CHD and provide a mechanism for unexplained phenotypes of mitochondrial disease.

12 January 2022 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
Stephanie WareStephanie Ware
Stephanie Ware
SBSurbhi Bhatnagar
Surbhi Bhatnagar
PDPhillip J. Dexheimer
Phillip J. Dexheimer
JWJames D. Wilkinson
James D. Wilkinson
ASArthi Sridhar
Arthi Sridhar
SLSteven E. Lipshultz
Steven E. Lipshultz